SHORT MINI-FUTURE - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 11:34:41 17/05/2024 pm IST | ||
| 14.06 EUR | -0.07% |
|
| Current month | -9.41% | ||
| 1 month | -20.20% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 14.06 | -0.07% |
| 16/24/16 | 14.07 | +4.69% |
| 15/24/15 | 13.44 | -7.50% |
| 14/24/14 | 14.53 | -0.68% |
| 13/24/13 | 14.63 | -1.42% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 11:34 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ9GKQ |
| ISIN | DE000VQ9GKQ7 |
| Date issued | 12/07/2021 |
| Strike | 381.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.66 € |
|---|---|
| Lowest since issue | 2.56 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
230.6
USD
Average target price
285.9
USD
Spread / Average Target
+24.01%
- Stock Market
- Certificates
- Certificat
